Bank of Montreal
RVPH

Bank of Montreal’s REVIVA PHARMA HLDGS INC RVPH Stock Holding History

Bank of Montreal’s Portfolio RVPH Stock Details RVPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-34,703
Closed -$7.29M – 4803
2020
Q1 		$7.29M Buy
34,703
+18,603
+116% +$3.9M 0.01% 829
2019
Q4 		$3.37M Hold
16,100
– – ﹤0.01% 1585
2019
Q3 		$3.33M Hold
16,100
– – ﹤0.01% 1380
2019
Q2 		$3.31M Hold
16,100
– – ﹤0.01% 1412
2019
Q1 		$3.24M Buy
+16,100
New +$3.23M ﹤0.01% 1408

Other funds holding RVPH

Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
MSU
Mizuho Securities USA New York $6.2B AUM 35.46% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $1.14B AUM 6.91% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
WRBC
W.R. Berkley Corp Greenwich, Connecticut $1.86B AUM 14.44% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
GCIA
Gabelli & Co Investment Advisers Rye, New York $674M AUM 64.46% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

Bank of Montreal's RVPH Position: Q2 2020 in Review

Bank of Montreal sold out of REVIVA PHARMA HLDGS INC (RVPH) in Q2 2020, closing a stake of 34,703 shares — an estimated $7.29M sold.

Bank of Montreal first reported a position in RVPH in Q1 2019 and held it in 5 quarters. The position peaked at $7.29M in Q1 2020. 16 funds tracked by Wall St. Rank hold RVPH as of Q2 2020.

  • Bank of Montreal reported no remaining REVIVA PHARMA HLDGS INC position as of Q2 2020 after selling out during the quarter.
  • Bank of Montreal sold 34,703 REVIVA PHARMA HLDGS INC shares in Q2 2020, an estimated $7.29M.
  • Bank of Montreal first reported a position in REVIVA PHARMA HLDGS INC in Q1 2019 and held it in 5 quarters.
  • Bank of Montreal's REVIVA PHARMA HLDGS INC position peaked at $7.29M in Q1 2020.
  • 16 funds tracked by Wall St. Rank held REVIVA PHARMA HLDGS INC as of Q2 2020.

Based on Bank of Montreal's 13F filing for Q2 2020, filed 12 Aug 2020.